4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001415889-25-002292
CEO AND PRESIDENT bought 9,542 shares at an average $5.27 ($50,303)
- CEO AND PRESIDENT acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Szela Mary T CEO AND PRESIDENT | 2025-01-27 | Grant or award | +40,000 | 424,677 | D | ||
| Szela Mary T CEO AND PRESIDENT | 2025-01-27 | Purchase | +4,826 | $5.42 | $26,157 | 429,503 | D |
| Szela Mary T CEO AND PRESIDENT | 2025-01-28 | Purchase | +4,716 | $5.12 | $24,146 | 434,219 | D |
| Derivatives | |||||||
| Szela Mary T CEO AND PRESIDENT | 2025-01-27 | Grant or award · Employee Stock Option (right to buy) | +240,000 | 240,000 | D | ||
| Open-market purchases · 9,542 sh · avg $5.27 · $50,303 | |||||||
Loading xslF345X05/form4-01292025_110101.xml…